Evidence map›Paper›PMID 38609430›Full record

ArticleCommunications chemistry2024

Predicting permeation of compounds across the outer membrane of P. aeruginosa using molecular descriptors.

Pedro D Manrique, Inga V Leus, César A López, Jitender Mehla, Giuliano Malloci, Silvia Gervasoni, Attilio V Vargiu, Rama K Kinthada, Liam Herndon, Nicolas W Hengartner and 5 more

Open access · goldAbstract read
In one paragraph

Article in Communications chemistry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Antibiotic resistance inFrontiers in microbiology · 2026
    Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 2 countries.

Pedro D ManriquePhysics Department, George Washington University, Washington, 20052, DC, USA. pmanriq@gmail.com.ORCID http://orcid.org/0000-0001-6715-8660
Inga V LeusDepartment of Chemistry and Biochemistry, University of Oklahoma, Norman, 73019, OK, USA.ORCID http://orcid.org/0000-0001-8906-717X
César A LópezTheoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, 87545, NM, USA.
Jitender MehlaDepartment of Chemistry and Biochemistry, University of Oklahoma, Norman, 73019, OK, USA.ORCID http://orcid.org/0000-0002-7829-557X
Giuliano MallociDepartment of Physics, University of Cagliari, Monserrato, 20052, CA, Italy.ORCID http://orcid.org/0000-0002-5985-257X
Silvia GervasoniDepartment of Physics, University of Cagliari, Monserrato, 20052, CA, Italy.ORCID http://orcid.org/0000-0002-5731-3396
Attilio V VargiuDepartment of Physics, University of Cagliari, Monserrato, 20052, CA, Italy.
Rama K KinthadaDepartment of Pharmacology and Physiology, Saint Louis University, St. Louis, 63103, MO, USA.
Liam HerndonTheoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, 87545, NM, USA.
Nicolas W HengartnerTheoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, 87545, NM, USA.
John K WalkerDepartment of Pharmacology and Physiology, Saint Louis University, St. Louis, 63103, MO, USA.
Valentin V RybenkovDepartment of Chemistry and Biochemistry, University of Oklahoma, Norman, 73019, OK, USA.ORCID http://orcid.org/0000-0002-5300-4369
Paolo RuggeroneDepartment of Physics, University of Cagliari, Monserrato, 20052, CA, Italy.ORCID http://orcid.org/0000-0003-0825-0824
Helen I ZgurskayaDepartment of Chemistry and Biochemistry, University of Oklahoma, Norman, 73019, OK, USA.ORCID http://orcid.org/0000-0001-8929-4727
S GnanakaranTheoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, 87545, NM, USA. gnana@lanl.gov.ORCID http://orcid.org/0000-0002-9368-3044
Los Alamos National Laboratory · USUniversity of Cagliari · ITUniversity of Oklahoma · USSaint Louis University · USGeorge Washington University · US

Funding

Predictive Models for Small-Molecule Accumulation in Gram-Negative BacteriaR01AI136795 · NIAID · SLOAN-KETTERING INST CAN RESEARCH · PI TAN, DEREK S, ZGURSKAYA, HELEN I · 2018 to 2022
$6.5M
Optimization of efflux avoidance and inhibition for antibiotic developmentR01AI136799 · NIAID · UNIVERSITY OF OKLAHOMA · PI GNANAKARAN, SANDRASEGARAM, RUGGERONE, PAOLO · 2018 to 2022
$5.7M
NIAID NIH HHS R01 AI136795NIAID NIH HHS R01 AI136799
6 · The paper itself

Abstract

The ability Gram-negative pathogens have at adapting and protecting themselves against antibiotics has increasingly become a public health threat. Data-driven models identifying molecular properties that correlate with outer membrane (OM) permeation and growth inhibition while avoiding efflux could guide the discovery of novel classes of antibiotics. Here we evaluate 174 molecular descriptors in 1260 antimicrobial compounds and study their correlations with antibacterial activity in Gram-negative Pseudomonas aeruginosa. The descriptors are derived from traditional approaches quantifying the compounds' intrinsic physicochemical properties, together with, bacterium-specific from ensemble docking of compounds targeting specific MexB binding pockets, and all-atom molecular dynamics simulations in different subregions of the OM model. Using these descriptors and the measured inhibitory concentrations, we design a statistical protocol to identify predictors of OM permeation/inhibition. We find consistent rules across most of our data highlighting the role of the interaction between the compounds and the OM. An implementation of the rules uncovered in our study is shown, and it demonstrates the accuracy of our approach in a set of previously unseen compounds. Our analysis sheds new light on the key properties drug candidates need to effectively permeate/inhibit P. aeruginosa, and opens the gate to similar data-driven studies in other Gram-negative pathogens.

Identifiers

PMID38609430
PMCPMC11015012
OpenAlexW4394769640

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.